Physician profile
Eric W Price
NPI 1174611032
$10,517.35
in general payments reported to CMS, 2019-2025
15 companies · $2,890 in 2025
The $2,890 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,347 · 2020: $2,707 · 2021: $391 · 2022: $1,000 · 2023: $522 · 2024: $661 · 2025: $2,890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,380 · Food and Beverage: $1,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,380.41 |
| Food and Beverage | $1,692.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,754.31 | 2019-2025 | Persona, Comprehensive Shoulder System |
| Intellijoint Surgical INC. | $2,527.26 | 2019-2020 | |
| Stryker Corporation | $1,687.12 | 2019-2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Depuy Synthes Sales INC. | $504.80 | 2019-2025 | Monovisc, Dynatape, Fms |
| Medacta USA, INC. | $413.69 | 2019-2023 | Reverse Shoulder, Gmk Sphere |
| Sanara Medtech INC. | $128.66 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $119.74 | 2025 | Exparel |
| Catalyst Orthoscience | $80.02 | 2022 | |
| Integrity Orthopaedics, INC. | $67.35 | 2025 | Integrity Orthopaedics |
| Abbott Laboratories | $65.09 | 2019-2021 | |
| Bioventus LLC | $62.00 | 2023-2024 | Durolane, Durolane |
| Pacira Therapeutics, INC. | $51.05 | 2019-2020 | |
| Vericel Corporation | $21.98 | 2022 | |
| Omnilife Science, INC | $20.76 | 2020 | |
| Becton, Dickinson and Company | $13.52 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,599,989.23 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.